Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile
Pradeep Yadav

@pradeepyadavmd

Interventional Cardiologist, Structural Heart Disease, #TranscatheterTreatmentOfValveDisease, #Innovation. Tweets are my own opinion

ID: 888568135850373120

calendar_today22-07-2017 01:15:27

2,2K Tweet

4,4K Followers

711 Following

Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

Pi-Cardia Shortcut FDA approved! What a great news! Best dedicated device to make the procedure simpler and more accessible! Congratulations investigators!

DASI Simulations LLC (@dasisimulations) 's Twitter Profile Photo

Hear what the experts have to say about DASI Simulations. Join our Sponsored Satellite Breakfast at #TCT2024. You don’t want to miss Gui Attizzani Pradeep Yadav discuss the future of AI in structural heart procedures. Meet us in Room 207B, Level 2, Walter E. Washington

Hear what the experts have to say about DASI Simulations. Join our Sponsored Satellite Breakfast at #TCT2024. You don’t want to miss <a href="/GuiAttizzaniMD/">Gui Attizzani</a>   <a href="/PradeepYadavMD/">Pradeep Yadav</a> discuss the future of AI in structural heart procedures. Meet us in Room 207B, Level 2, Walter E. Washington
Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

Anterior leaflet modification (aka destruction) before #TMVR placement. Simple, many less steps, probably wider split than traditional laceration. Obviously, for carefully selected cases. Thanks Amar Krishnaswamy for sharing his experience.

Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

Dear Aetna Aetna Aetna News, apologize we have no where to go, so coming to X. We need some help addressing your denials of certain newer procedures (on FDA approved devices, which are routinely approved by other payors). Very frustrating for these sick patients. Maybe

Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

Welcome ⁦thoughtful National Coverage Analysis on #TTVR published yesterday. Access to healthcare is critical and ⁦CMSGov⁩ decision is a testament. Great job! Treatment for TR enters a new era! ⁦SCAI⁩ ⁦American College of Cardiology⁩ cms.gov/medicare-cover…

Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

MiRus Siegel™ TAVR: First EFS Cases Honored to launch EFS Piedmont great technological advance for #TAVR, looking forward to next steps ⁦MiRus⁩ ⁦American College of Cardiology⁩ #ACC2025 ⁦SCAI⁩ prnewswire.com/news-releases/…

Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

Get hands-on with the future of structural heart training with Dr. Rebecca T. Hahn (RTHahnMD) at #NYValves2025! Through iCOACH, New York Valves reimagines how you learn — with live demos, step-by-step procedural walkthroughs, and expert-led imaging tips you won’t find anywhere

Pradeep Yadav (@pradeepyadavmd) 's Twitter Profile Photo

Severe Nickel Allergy Patient Treated with Novel Siegel Transcatheter Heart Valve - ⁦⁦MiRus⁩ Will be interesting to see in future ”IF” Nickel Allergy plays a role in #HALT #TAVR ⁦Piedmont⁩ ⁦SCAI⁩ ⁦American College of Cardiology⁩ piedmont.org/about-piedmont…

Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

Advance your structural heart expertise at #NYValves2025 – where visionaries unite to shape the future of care! Don’t miss these high-impact sessions and experiences: 📍 CRF Welcome Reception – Wednesday, June 25 | 5:45 PM–7:00 PM 🔍 Imaging Learning Center →

Kashish Goel (@kashishgoelmd) 's Twitter Profile Photo

Severe TR—before or after transseptal MViV—is a prognostic signal. In >5,000 patients, residual severe TR at 30 days was linked to significantly higher 3-year mortality. Interestingly, mortality curves diverge after 1 year (timeline used in most pivotal trials). TR is not a

Severe TR—before or after transseptal MViV—is a prognostic signal. In &gt;5,000 patients, residual severe TR at 30 days was linked to significantly higher 3-year mortality. 

Interestingly, mortality curves diverge after 1 year (timeline used in most pivotal trials). TR is not a
Cardiovascular Research Foundation (@crfheart) 's Twitter Profile Photo

🗽 Start Planning Your #NYValves2025 Experience! From world-class education to hands-on training and next-level networking, the premier structural heart meeting has it all. 💥 Explore must-attend sessions, build your schedule, and get ready to take on NYC. Let the countdown